Durvalumab (MEDI 4736) is an humanized anti-PD-L1 monoclonal antibody, it completely blocks the binding of PD-L1 to both PD-1 and CD80, with IC50s of 0.1 and 0.04 nM, respectively. Durvalumab was inactive against the mPD-L1.
Purity:
>99%
CAS Number:
[1428935-60-7]
Target:
PD-1/PD-L1
* VAT and and shipping costs not included. Errors and price changes excepted
